Share Price and Basic Stock Data
Last Updated: February 3, 2026, 4:02 am
| PEG Ratio | -7.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
GRM Overseas Ltd, an entity in the agricultural products sector, reported a market capitalization of ₹2,998 Cr and a share price of ₹163. The company has experienced fluctuating sales over recent quarters, with revenue standing at ₹1,262 Cr for FY 2023. This represents a growth from ₹1,098 Cr in FY 2022. However, sales have shown volatility, with the latest quarter (Sep 2023) recording a decline to ₹165.60 Cr from ₹297.32 Cr in Jun 2023. The trailing twelve months (TTM) revenue is ₹1,034 Cr, indicating a downward trend in recent periods. GRM’s sales figures exhibit a historical peak of ₹1,068 Cr in FY 2019, followed by a decline in subsequent years, which raises concerns regarding sales stability. The company’s operating profit margin stood at 4.29% as of the latest quarter, reflecting pressure on profitability amid fluctuating revenues. Overall, while GRM has a solid historical sales base, the recent revenue trends highlight a need for strategic measures to stabilize and enhance growth.
Profitability and Efficiency Metrics
GRM Overseas has reported a net profit of ₹53 Cr for the trailing twelve months, with a net profit margin of 5.58% for FY 2025. This is a decline from ₹79 Cr in FY 2022 and ₹54 Cr in FY 2023, indicating challenges in maintaining profitability. The company’s operating profit margin (OPM) has been inconsistent, with the latest figure at 4.29%, reflecting a decrease from 8% in FY 2022. Efficiency metrics reveal a cash conversion cycle (CCC) of 329 days, significantly higher than industry norms, suggesting inefficiencies in managing working capital. The return on equity (ROE) at 14.6% and return on capital employed (ROCE) at 12.1% are relatively strong, indicating effective utilization of equity and capital. However, these returns are lower compared to previous years, where ROE peaked at 38.97% in FY 2022. Thus, while GRM demonstrates some effective operational management, the declining profitability and high CCC raise concerns about operational efficiency moving forward.
Balance Sheet Strength and Financial Ratios
The balance sheet of GRM Overseas reflects a total debt of ₹211 Cr against reserves of ₹420 Cr, providing a debt-to-equity ratio of approximately 0.93. This indicates a manageable leverage position compared to typical industry standards. The interest coverage ratio (ICR) stands at 5.12x, suggesting that the company comfortably meets its interest obligations. However, the declining trend in total liabilities, which stood at ₹865 Cr in FY 2025, compared to ₹761 Cr in FY 2023, raises questions about long-term financial stability. The current ratio of 1.73 and quick ratio of 1.09 indicate adequate short-term liquidity. Furthermore, the price-to-book value ratio (P/BV) is 4.05x, suggesting that the stock is valued at a premium relative to its book value, which may not be sustainable if profitability continues to decline. Overall, while the balance sheet shows strength in terms of liquidity and leverage, the declining profitability and asset management efficiency could pose risks in the long term.
Shareholding Pattern and Investor Confidence
As of the latest reporting, GRM Overseas has a promoter holding of 68.27%, reflecting strong insider confidence in the company. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 5.54% and 1.63% respectively, indicating limited institutional interest. The public shareholding stands at 24.57%, with a total of 23,656 shareholders, which shows a relatively broad base of retail investors. The shareholding pattern has seen gradual fluctuations, particularly with FIIs increasing their stake from 0.07% in Mar 2023 to 5.54% in Dec 2025. This trend may indicate growing confidence among institutional investors, which could be a positive signal for potential investments. However, the declining promoter shareholding from 72.43% in Mar 2025 to 68.27% in Dec 2025 may raise concerns about insider confidence. Thus, while there is a solid promoter base, the mixed signals from institutional investors could affect overall market sentiment.
Outlook, Risks, and Final Insight
The outlook for GRM Overseas hinges on its ability to stabilize revenue and improve profitability amidst operational challenges. The volatility in sales, particularly the recent declines, poses a significant risk to future growth. Additionally, the high cash conversion cycle indicates inefficiencies that need addressing to enhance working capital management. On the positive side, the company’s strong balance sheet and manageable debt levels suggest that it is well-positioned to weather short-term challenges. However, the declining profitability metrics and fluctuating investor confidence signal potential headwinds. If GRM can successfully implement operational improvements and regain sales momentum, it may reverse recent trends and enhance shareholder value. Conversely, persistent inefficiencies and declining margins could lead to a further deterioration of its financial position, necessitating close monitoring of its strategic initiatives moving forward.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,998 Cr. | 163 | 186/65.8 | 56.6 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 144 Cr. | 180 | 200/105 | 64.2 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.2/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,175 Cr. | 236 | 396/228 | 12.5 | 153 | 1.06 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 390 Cr. | 11.8 | 18.5/11.3 | 14.1 | 6.86 | 0.08 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,586.10 Cr | 228.47 | 29.14 | 106.69 | 0.35% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258.97 | 330.83 | 359.38 | 297.32 | 165.60 | 357.47 | 365.44 | 275.90 | 149.92 | 244.51 | 242.82 | 255.93 | 290.86 |
| Expenses | 240.74 | 310.28 | 341.56 | 275.54 | 158.04 | 342.10 | 350.99 | 255.29 | 141.82 | 234.91 | 215.90 | 235.71 | 278.38 |
| Operating Profit | 18.23 | 20.55 | 17.82 | 21.78 | 7.56 | 15.37 | 14.45 | 20.61 | 8.10 | 9.60 | 26.92 | 20.22 | 12.48 |
| OPM % | 7.04% | 6.21% | 4.96% | 7.33% | 4.57% | 4.30% | 3.95% | 7.47% | 5.40% | 3.93% | 11.09% | 7.90% | 4.29% |
| Other Income | -0.46 | 8.05 | 3.70 | 5.54 | 6.61 | 8.59 | 11.48 | 5.16 | 4.72 | 10.98 | 4.46 | 7.68 | 5.25 |
| Interest | 3.18 | 5.49 | 5.76 | 5.53 | 4.08 | 5.13 | 5.74 | 3.55 | 2.44 | 3.75 | 7.95 | 5.43 | 5.09 |
| Depreciation | 0.74 | 0.79 | 1.36 | 0.83 | 0.84 | 0.86 | 1.01 | 0.69 | 0.76 | 0.71 | 0.81 | 0.77 | 0.75 |
| Profit before tax | 13.85 | 22.32 | 14.40 | 20.96 | 9.25 | 17.97 | 19.18 | 21.53 | 9.62 | 16.12 | 22.62 | 21.70 | 11.89 |
| Tax % | 24.55% | 26.52% | 38.61% | 25.19% | 26.81% | 26.21% | 18.20% | 25.27% | 25.99% | 25.87% | 29.93% | 24.79% | 25.90% |
| Net Profit | 10.44 | 16.40 | 8.85 | 15.68 | 6.77 | 13.26 | 15.68 | 16.08 | 7.12 | 11.95 | 15.86 | 16.32 | 8.81 |
| EPS in Rs | 0.58 | 0.91 | 0.49 | 0.87 | 0.38 | 0.74 | 0.87 | 0.89 | 0.40 | 0.66 | 0.88 | 0.89 | 0.48 |
Last Updated: December 26, 2025, 5:05 pm
Below is a detailed analysis of the quarterly data for GRM Overseas Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 290.86 Cr.. The value appears strong and on an upward trend. It has increased from 255.93 Cr. (Jun 2025) to 290.86 Cr., marking an increase of 34.93 Cr..
- For Expenses, as of Sep 2025, the value is 278.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 235.71 Cr. (Jun 2025) to 278.38 Cr., marking an increase of 42.67 Cr..
- For Operating Profit, as of Sep 2025, the value is 12.48 Cr.. The value appears to be declining and may need further review. It has decreased from 20.22 Cr. (Jun 2025) to 12.48 Cr., marking a decrease of 7.74 Cr..
- For OPM %, as of Sep 2025, the value is 4.29%. The value appears to be declining and may need further review. It has decreased from 7.90% (Jun 2025) to 4.29%, marking a decrease of 3.61%.
- For Other Income, as of Sep 2025, the value is 5.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.68 Cr. (Jun 2025) to 5.25 Cr., marking a decrease of 2.43 Cr..
- For Interest, as of Sep 2025, the value is 5.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.43 Cr. (Jun 2025) to 5.09 Cr., marking a decrease of 0.34 Cr..
- For Depreciation, as of Sep 2025, the value is 0.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.77 Cr. (Jun 2025) to 0.75 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 11.89 Cr.. The value appears to be declining and may need further review. It has decreased from 21.70 Cr. (Jun 2025) to 11.89 Cr., marking a decrease of 9.81 Cr..
- For Tax %, as of Sep 2025, the value is 25.90%. The value appears to be increasing, which may not be favorable. It has increased from 24.79% (Jun 2025) to 25.90%, marking an increase of 1.11%.
- For Net Profit, as of Sep 2025, the value is 8.81 Cr.. The value appears to be declining and may need further review. It has decreased from 16.32 Cr. (Jun 2025) to 8.81 Cr., marking a decrease of 7.51 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.48. The value appears to be declining and may need further review. It has decreased from 0.89 (Jun 2025) to 0.48, marking a decrease of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 422 | 568 | 355 | 591 | 924 | 1,068 | 739 | 748 | 1,098 | 1,262 | 1,186 | 912 | 1,034 |
| Expenses | 406 | 544 | 341 | 571 | 889 | 1,026 | 687 | 690 | 1,013 | 1,177 | 1,127 | 846 | 965 |
| Operating Profit | 16 | 24 | 14 | 20 | 35 | 42 | 52 | 59 | 85 | 86 | 59 | 65 | 69 |
| OPM % | 4% | 4% | 4% | 3% | 4% | 4% | 7% | 8% | 8% | 7% | 5% | 7% | 7% |
| Other Income | -0 | -0 | 0 | -0 | 0 | 1 | 13 | 5 | 37 | 12 | 32 | 25 | 28 |
| Interest | 7 | 14 | 9 | 10 | 15 | 16 | 14 | 12 | 13 | 19 | 20 | 18 | 22 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 3 | 3 |
| Profit before tax | 7 | 8 | 3 | 8 | 18 | 25 | 48 | 49 | 106 | 75 | 67 | 70 | 72 |
| Tax % | 33% | 42% | 34% | 34% | 35% | 35% | 24% | 25% | 26% | 28% | 24% | 27% | |
| Net Profit | 5 | 5 | 2 | 6 | 12 | 16 | 36 | 37 | 79 | 54 | 51 | 51 | 53 |
| EPS in Rs | 0.88 | 0.83 | 0.37 | 1.01 | 2.12 | 2.94 | 6.55 | 6.20 | 13.14 | 8.93 | 8.56 | 8.50 | 8.73 |
| Dividend Payout % | 15% | 0% | 0% | 0% | 16% | 11% | 5% | 22% | 70% | 5% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -60.00% | 200.00% | 100.00% | 33.33% | 125.00% | 2.78% | 113.51% | -31.65% | -5.56% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -60.00% | 260.00% | -100.00% | -66.67% | 91.67% | -122.22% | 110.74% | -145.16% | 26.09% | 5.56% |
GRM Overseas Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 4% |
| 3 Years: | -6% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 7% |
| 3 Years: | -14% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 74% |
| 3 Years: | -8% |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 24% |
| 3 Years: | 18% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 10, 2025, 4:25 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 26 | 31 | 33 | 38 | 50 | 64 | 98 | 135 | 192 | 243 | 294 | 380 | 420 |
| Borrowings | 143 | 155 | 132 | 198 | 292 | 348 | 210 | 188 | 331 | 407 | 393 | 364 | 211 |
| Other Liabilities | 38 | 55 | 15 | 59 | 64 | 62 | 60 | 89 | 119 | 99 | 38 | 109 | 178 |
| Total Liabilities | 211 | 244 | 183 | 299 | 410 | 478 | 372 | 416 | 655 | 761 | 737 | 865 | 821 |
| Fixed Assets | 22 | 22 | 21 | 21 | 21 | 31 | 37 | 35 | 36 | 37 | 36 | 39 | 38 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 2 | 2 | 12 | 12 |
| Other Assets | 189 | 222 | 162 | 278 | 387 | 442 | 333 | 380 | 618 | 722 | 700 | 814 | 771 |
| Total Assets | 211 | 244 | 183 | 299 | 410 | 478 | 372 | 416 | 655 | 761 | 737 | 865 | 821 |
Below is a detailed analysis of the balance sheet data for GRM Overseas Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 420.00 Cr.. The value appears strong and on an upward trend. It has increased from 380.00 Cr. (Mar 2025) to 420.00 Cr., marking an increase of 40.00 Cr..
- For Borrowings, as of Sep 2025, the value is 211.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 364.00 Cr. (Mar 2025) to 211.00 Cr., marking a decrease of 153.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.00 Cr. (Mar 2025) to 178.00 Cr., marking an increase of 69.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 821.00 Cr.. The value appears to be improving (decreasing). It has decreased from 865.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 44.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Other Assets, as of Sep 2025, the value is 771.00 Cr.. The value appears to be declining and may need further review. It has decreased from 814.00 Cr. (Mar 2025) to 771.00 Cr., marking a decrease of 43.00 Cr..
- For Total Assets, as of Sep 2025, the value is 821.00 Cr.. The value appears to be declining and may need further review. It has decreased from 865.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 44.00 Cr..
Notably, the Reserves (420.00 Cr.) exceed the Borrowings (211.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -127.00 | -131.00 | -118.00 | -178.00 | -257.00 | -306.00 | -158.00 | -129.00 | -246.00 | -321.00 | -334.00 | -299.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 83 | 85 | 46 | 74 | 93 | 135 | 134 | 134 | 116 | 144 | 186 |
| Inventory Days | 124 | 68 | 77 | 146 | 90 | 63 | 33 | 56 | 79 | 108 | 76 | 154 |
| Days Payable | 35 | 34 | 14 | 18 | 24 | 16 | 21 | 27 | 32 | 25 | 9 | 11 |
| Cash Conversion Cycle | 137 | 117 | 148 | 174 | 140 | 140 | 147 | 164 | 182 | 198 | 210 | 329 |
| Working Capital Days | 29 | 32 | 44 | 43 | 13 | 10 | 31 | 49 | 55 | 63 | 81 | 123 |
| ROCE % | 10% | 12% | 7% | 9% | 11% | 10% | 17% | 19% | 28% | 16% | 12% | 12% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 8.50 | 8.56 | 8.93 | 13.17 | 98.32 |
| Diluted EPS (Rs.) | 7.38 | 8.56 | 8.93 | 13.17 | 98.32 |
| Cash EPS (Rs.) | 9.00 | 9.15 | 9.54 | 13.64 | 100.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 64.95 | 50.75 | 42.19 | 33.71 | 348.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 65.27 | 51.08 | 42.51 | 34.03 | 353.82 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.45 | 2.65 | 20.00 |
| Revenue From Operations / Share (Rs.) | 152.19 | 197.64 | 210.41 | 183.07 | 1974.83 |
| PBDIT / Share (Rs.) | 15.09 | 15.23 | 16.24 | 20.32 | 161.44 |
| PBIT / Share (Rs.) | 14.60 | 14.64 | 15.63 | 19.82 | 154.30 |
| PBT / Share (Rs.) | 11.65 | 11.23 | 12.43 | 17.69 | 124.76 |
| Net Profit / Share (Rs.) | 8.50 | 8.56 | 8.93 | 13.14 | 92.96 |
| PBDIT Margin (%) | 9.91 | 7.70 | 7.71 | 11.09 | 8.17 |
| PBIT Margin (%) | 9.59 | 7.40 | 7.42 | 10.82 | 7.81 |
| PBT Margin (%) | 7.65 | 5.68 | 5.90 | 9.66 | 6.31 |
| Net Profit Margin (%) | 5.58 | 4.33 | 4.24 | 7.17 | 4.70 |
| Return on Networth / Equity (%) | 13.08 | 16.87 | 21.16 | 38.97 | 26.64 |
| Return on Capital Employeed (%) | 22.15 | 28.45 | 36.42 | 57.54 | 43.00 |
| Return On Assets (%) | 5.89 | 6.97 | 7.03 | 12.04 | 8.79 |
| Total Debt / Equity (X) | 0.93 | 1.29 | 1.61 | 1.64 | 1.36 |
| Asset Turnover Ratio (%) | 1.14 | 1.58 | 1.78 | 2.05 | 1.97 |
| Current Ratio (X) | 1.73 | 1.63 | 1.43 | 1.38 | 1.37 |
| Quick Ratio (X) | 1.09 | 1.14 | 0.82 | 0.95 | 1.04 |
| Inventory Turnover Ratio (X) | 3.55 | 4.56 | 4.60 | 6.74 | 8.36 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 5.04 | 20.16 | 26.55 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 4.71 | 19.42 | 24.65 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 94.96 | 79.84 | 73.45 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 95.29 | 80.58 | 75.35 |
| Interest Coverage Ratio (X) | 5.12 | 4.46 | 5.09 | 9.57 | 5.46 |
| Interest Coverage Ratio (Post Tax) (X) | 3.88 | 3.51 | 3.80 | 7.19 | 4.15 |
| Enterprise Value (Cr.) | 1906.74 | 1097.76 | 1506.25 | 4175.26 | 817.60 |
| EV / Net Operating Revenue (X) | 2.09 | 0.92 | 1.19 | 3.80 | 1.05 |
| EV / EBITDA (X) | 21.06 | 12.01 | 15.46 | 34.25 | 12.85 |
| MarketCap / Net Operating Revenue (X) | 1.73 | 0.60 | 0.87 | 3.50 | 0.81 |
| Retention Ratios (%) | 0.00 | 0.00 | 94.95 | 79.83 | 73.44 |
| Price / BV (X) | 4.05 | 2.34 | 4.35 | 19.02 | 4.60 |
| Price / Net Operating Revenue (X) | 1.73 | 0.60 | 0.87 | 3.50 | 0.81 |
| EarningsYield | 0.03 | 0.07 | 0.04 | 0.02 | 0.05 |
After reviewing the key financial ratios for GRM Overseas Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 8.50, marking a decrease of 0.06.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.38. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 7.38, marking a decrease of 1.18.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.00. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 9.00, marking a decrease of 0.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.95. It has increased from 50.75 (Mar 24) to 64.95, marking an increase of 14.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 65.27. It has increased from 51.08 (Mar 24) to 65.27, marking an increase of 14.19.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 152.19. It has decreased from 197.64 (Mar 24) to 152.19, marking a decrease of 45.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.09. This value is within the healthy range. It has decreased from 15.23 (Mar 24) to 15.09, marking a decrease of 0.14.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.60. This value is within the healthy range. It has decreased from 14.64 (Mar 24) to 14.60, marking a decrease of 0.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.65. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 11.65, marking an increase of 0.42.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 8.50, marking a decrease of 0.06.
- For PBDIT Margin (%), as of Mar 25, the value is 9.91. This value is below the healthy minimum of 10. It has increased from 7.70 (Mar 24) to 9.91, marking an increase of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 10. It has increased from 7.40 (Mar 24) to 9.59, marking an increase of 2.19.
- For PBT Margin (%), as of Mar 25, the value is 7.65. This value is below the healthy minimum of 10. It has increased from 5.68 (Mar 24) to 7.65, marking an increase of 1.97.
- For Net Profit Margin (%), as of Mar 25, the value is 5.58. This value is within the healthy range. It has increased from 4.33 (Mar 24) to 5.58, marking an increase of 1.25.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.08. This value is below the healthy minimum of 15. It has decreased from 16.87 (Mar 24) to 13.08, marking a decrease of 3.79.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.15. This value is within the healthy range. It has decreased from 28.45 (Mar 24) to 22.15, marking a decrease of 6.30.
- For Return On Assets (%), as of Mar 25, the value is 5.89. This value is within the healthy range. It has decreased from 6.97 (Mar 24) to 5.89, marking a decrease of 1.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.93. This value is within the healthy range. It has decreased from 1.29 (Mar 24) to 0.93, marking a decrease of 0.36.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.58 (Mar 24) to 1.14, marking a decrease of 0.44.
- For Current Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 1.73, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.09, marking a decrease of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.55. This value is below the healthy minimum of 4. It has decreased from 4.56 (Mar 24) to 3.55, marking a decrease of 1.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.12. This value is within the healthy range. It has increased from 4.46 (Mar 24) to 5.12, marking an increase of 0.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 3.88, marking an increase of 0.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,906.74. It has increased from 1,097.76 (Mar 24) to 1,906.74, marking an increase of 808.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 2.09, marking an increase of 1.17.
- For EV / EBITDA (X), as of Mar 25, the value is 21.06. This value exceeds the healthy maximum of 15. It has increased from 12.01 (Mar 24) to 21.06, marking an increase of 9.05.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 1.73, marking an increase of 1.13.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 4.05. This value exceeds the healthy maximum of 3. It has increased from 2.34 (Mar 24) to 4.05, marking an increase of 1.71.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 1.73, marking an increase of 1.13.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GRM Overseas Ltd:
- Net Profit Margin: 5.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.15% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.08% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.09
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 56.6 (Industry average Stock P/E: 29.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.93
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 128, First Floor, Shiva Market, Delhi Delhi 110034 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Atul Garg | Chairman & Managing Director |
| Mrs. Mamta Garg | Executive Director |
| Mr. Hukam Chand Garg | Non Executive Director |
| Mr. Nipun Jain | Non Executive Director |
| Mr. Raj Kumar Garg | Independent Director |
| Mr. Gautam Gupta | Independent Director |
| Mr. Tarun Singh | Independent Director |
| Ms. Nidhi | Independent Director |
FAQ
What is the intrinsic value of GRM Overseas Ltd?
GRM Overseas Ltd's intrinsic value (as of 06 February 2026) is ₹146.02 which is 10.42% lower the current market price of ₹163.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,998 Cr. market cap, FY2025-2026 high/low of ₹186/65.8, reserves of ₹420 Cr, and liabilities of ₹821 Cr.
What is the Market Cap of GRM Overseas Ltd?
The Market Cap of GRM Overseas Ltd is 2,998 Cr..
What is the current Stock Price of GRM Overseas Ltd as on 06 February 2026?
The current stock price of GRM Overseas Ltd as on 06 February 2026 is ₹163.
What is the High / Low of GRM Overseas Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of GRM Overseas Ltd stocks is ₹186/65.8.
What is the Stock P/E of GRM Overseas Ltd?
The Stock P/E of GRM Overseas Ltd is 56.6.
What is the Book Value of GRM Overseas Ltd?
The Book Value of GRM Overseas Ltd is 23.5.
What is the Dividend Yield of GRM Overseas Ltd?
The Dividend Yield of GRM Overseas Ltd is 0.00 %.
What is the ROCE of GRM Overseas Ltd?
The ROCE of GRM Overseas Ltd is 12.1 %.
What is the ROE of GRM Overseas Ltd?
The ROE of GRM Overseas Ltd is 14.6 %.
What is the Face Value of GRM Overseas Ltd?
The Face Value of GRM Overseas Ltd is 2.00.